BRPI0416215A - forma de ministração individualmente dosada, não comprimida, processo para produzir uma forma de ministração individualmente dosada, não comprimida e uso de pelo menos um agente de estabilização - Google Patents

forma de ministração individualmente dosada, não comprimida, processo para produzir uma forma de ministração individualmente dosada, não comprimida e uso de pelo menos um agente de estabilização

Info

Publication number
BRPI0416215A
BRPI0416215A BRPI0416215-3A BRPI0416215A BRPI0416215A BR PI0416215 A BRPI0416215 A BR PI0416215A BR PI0416215 A BRPI0416215 A BR PI0416215A BR PI0416215 A BRPI0416215 A BR PI0416215A
Authority
BR
Brazil
Prior art keywords
uncompressed
individually dosed
stabilizing agent
delivery form
composition
Prior art date
Application number
BRPI0416215-3A
Other languages
English (en)
Portuguese (pt)
Inventor
Jose Luis Fabregas Vidal
Antoni Masso Carbonell
Nuria Garcia Gonzalez
Pere Guiro Coll
Original Assignee
Almirall Prodesfarma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34610359&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0416215(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Almirall Prodesfarma Sa filed Critical Almirall Prodesfarma Sa
Publication of BRPI0416215A publication Critical patent/BRPI0416215A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BRPI0416215-3A 2003-11-10 2004-11-09 forma de ministração individualmente dosada, não comprimida, processo para produzir uma forma de ministração individualmente dosada, não comprimida e uso de pelo menos um agente de estabilização BRPI0416215A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200302612A ES2235626B1 (es) 2003-11-10 2003-11-10 Formas de administracion masticables, no comprimidas dosificadas individualmente.
PCT/EP2004/012658 WO2005048974A2 (en) 2003-11-10 2004-11-09 Non-tabletted, chewable, individually dosed administration forms

Publications (1)

Publication Number Publication Date
BRPI0416215A true BRPI0416215A (pt) 2006-12-26

Family

ID=34610359

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0416215-3A BRPI0416215A (pt) 2003-11-10 2004-11-09 forma de ministração individualmente dosada, não comprimida, processo para produzir uma forma de ministração individualmente dosada, não comprimida e uso de pelo menos um agente de estabilização

Country Status (25)

Country Link
US (1) US20070134318A1 (enExample)
EP (1) EP1682097B1 (enExample)
JP (1) JP4879021B2 (enExample)
KR (1) KR20060116821A (enExample)
CN (1) CN1878542A (enExample)
AR (1) AR048050A1 (enExample)
AT (1) ATE492270T1 (enExample)
AU (1) AU2004290517B2 (enExample)
BR (1) BRPI0416215A (enExample)
CA (1) CA2548615A1 (enExample)
CO (1) CO5690531A2 (enExample)
DE (1) DE602004030706D1 (enExample)
EC (1) ECSP066553A (enExample)
ES (2) ES2235626B1 (enExample)
IL (1) IL175285A (enExample)
MY (1) MY143793A (enExample)
NO (1) NO20062723L (enExample)
NZ (1) NZ546375A (enExample)
PE (1) PE20050488A1 (enExample)
RU (1) RU2369379C2 (enExample)
TW (1) TW200526266A (enExample)
UA (1) UA90253C2 (enExample)
UY (1) UY28586A1 (enExample)
WO (2) WO2005048975A1 (enExample)
ZA (1) ZA200602416B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799832B2 (en) 2003-10-23 2010-09-21 Valeant Pharmaceuticals North America Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
US7960436B2 (en) 2006-06-05 2011-06-14 Valeant Pharmaceuticals International Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators
US8993593B2 (en) 2006-08-23 2015-03-31 Valeant Pharmaceuticals International N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators
PT2061465E (pt) 2006-08-23 2013-07-15 Valeant Pharmaceuticals Int Derivados de 4-(n-azacicloalquil)anilidas como moduladores do canal de potássio
CA2670966A1 (en) 2006-11-28 2008-06-05 Valeant Pharmaceuticals International 1,4 diamino bicyclic retigabine analogues as potassium channel modulators
US8367684B2 (en) 2007-06-13 2013-02-05 Valeant Pharmaceuticals International Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
EP2170282A4 (en) * 2007-06-27 2014-11-05 Hanmi Pharm Ind Co Ltd METHOD FOR PRODUCING A QUICKLY CRUSHING FORMULATION FOR ORAL ADMINISTRATION AND DEVICE FOR PREPARING AND PACKAGING THE FORMULATION
IL187159A0 (en) 2007-07-03 2009-02-11 Gur Megiddo Use of metadoxine in relief of alcohol intoxication
US7786146B2 (en) 2007-08-13 2010-08-31 Valeant Pharmaceuticals International Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
WO2010013242A1 (en) 2008-07-29 2010-02-04 Alcobra Ltd. Substituted pyridoxine-lactam carboxylate salts
EP2238976B1 (en) * 2009-04-03 2012-06-27 Hexal AG Oral films comprising 7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro- 1H-quinolin-2-one base or salts or hydrates thereof
CN102481291B (zh) 2009-06-25 2015-10-21 阿尔考布拉有限公司 用于治疗、减轻症状、缓解、改善和预防认知疾病、障碍或病症的方法
EA021368B1 (ru) * 2011-06-21 2015-06-30 Общество С Ограниченной Ответственностью "Консорциум-Пик" Препарат кардиопротекторного действия
CN105911057B (zh) * 2016-06-22 2018-10-19 扬州一洋制药有限公司 一种铝镁加混悬液的质量控制方法
TWI886158B (zh) 2019-10-10 2025-06-11 加拿大商再諾製藥公司 選擇性鉀通道調節劑之固態晶型
KR20220098746A (ko) 2019-11-08 2022-07-12 제논 파마슈티칼스 인크. 우울 장애 치료 방법
US11957675B2 (en) 2021-02-09 2024-04-16 Xenon Pharmaceuticals Inc. Methods and uses for treating anhedonia
CN113425694A (zh) * 2021-07-02 2021-09-24 杭州蚕宝生物技术有限公司 一种石斛生物碱口腔崩解片剂及其制备方法
US12053484B2 (en) 2021-10-29 2024-08-06 Medicated Chews, Llc Simethicone chewable composition

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5645411A (en) * 1979-09-20 1981-04-25 Taiho Yakuhin Kogyo Kk Poultice
FR2515035A1 (fr) * 1981-10-26 1983-04-29 Rhone Poulenc Sante Nouvelle forme galenique solide pour administration par voie orale et son procede de fabrication
EP0409432A3 (en) * 1989-07-20 1991-12-11 Warner-Lambert Company Confectionery delivery system
US5433951A (en) * 1993-10-13 1995-07-18 Bristol-Myers Squibb Company Sustained release formulation containing captopril and method
JPH08319232A (ja) * 1995-03-22 1996-12-03 Takeda Chem Ind Ltd 粉粒状組成物
JPH0912463A (ja) * 1995-06-23 1997-01-14 Fujisawa Pharmaceut Co Ltd 口中咀嚼用製剤
US20030216303A1 (en) * 1998-03-06 2003-11-20 Michael Ambuhl Emulsion preconcentrates containing cyclosporin or a macrolide
US6171615B1 (en) * 1998-07-06 2001-01-09 Gattefoss{acute over (e)} Sustained release theophylline formulations, excipient systems and methods of production
US6060078A (en) * 1998-09-28 2000-05-09 Sae Han Pharm Co., Ltd. Chewable tablet and process for preparation thereof
US6652880B1 (en) * 1999-04-01 2003-11-25 R.P. Scherer Technologies, Inc. Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants
EP2286793A3 (en) * 2001-02-14 2014-01-08 GW Pharma Limited Pharmaceutical formulations comprising cannabidiol
US6692771B2 (en) * 2001-02-23 2004-02-17 Cima Labs Inc. Emulsions as solid dosage forms for oral administration
RU2197094C1 (ru) * 2001-12-26 2003-01-27 Ставрулов Игорь Анатольевич Жевательная резинка

Also Published As

Publication number Publication date
CN1878542A (zh) 2006-12-13
UA90253C2 (ru) 2010-04-26
PE20050488A1 (es) 2005-08-24
ES2235626B1 (es) 2006-11-01
JP2007510690A (ja) 2007-04-26
TW200526266A (en) 2005-08-16
KR20060116821A (ko) 2006-11-15
MY143793A (en) 2011-07-15
WO2005048975A1 (en) 2005-06-02
CA2548615A1 (en) 2005-06-02
IL175285A0 (en) 2006-09-05
US20070134318A1 (en) 2007-06-14
EP1682097B1 (en) 2010-12-22
AR048050A1 (es) 2006-03-29
RU2006120087A (ru) 2007-12-27
JP4879021B2 (ja) 2012-02-15
ATE492270T1 (de) 2011-01-15
WO2005048974A3 (en) 2006-02-23
AU2004290517B2 (en) 2010-05-27
AU2004290517A1 (en) 2005-06-02
NZ546375A (en) 2009-11-27
WO2005048974A2 (en) 2005-06-02
DE602004030706D1 (de) 2011-02-03
ZA200602416B (en) 2009-06-24
NO20062723L (no) 2006-06-12
EP1682097A2 (en) 2006-07-26
ECSP066553A (es) 2006-12-20
RU2369379C2 (ru) 2009-10-10
IL175285A (en) 2011-04-28
ES2358332T3 (es) 2011-05-09
ES2235626A1 (es) 2005-07-01
CO5690531A2 (es) 2006-10-31
UY28586A1 (es) 2005-05-31

Similar Documents

Publication Publication Date Title
BRPI0416215A (pt) forma de ministração individualmente dosada, não comprimida, processo para produzir uma forma de ministração individualmente dosada, não comprimida e uso de pelo menos um agente de estabilização
AR073388A1 (es) Composiciones de limpieza estables que contienen productos tensioactivos de isetionato de acilo graso que tienen mas del 10% en peso de contenido de acido graso/jabon graso y que utilizan un alto nivel de poliol y metodos para las mismas
BR0011347A (pt) Preparações e formas de administração compreendendo um composto ativo de ácido instável
CL2020003068A1 (es) Composiciones de biomasa que contienen pectina activada, productos y métodos de producción
AR008583A1 (es) Composicion acida acuosa que contiene un ester de betaina de un alcohol activo y procedimiento para prerarar dicha composicion
BRPI0406924A (pt) Composições de fragrância
ES2058109T3 (es) Un procedimiento para la preparacion de una composicion farmaceutica antimicrobiana topica.
BRPI0417287A (pt) espuma oleosa para uso farmacêutico e cosmético
RU2015125076A (ru) С6-с18-ацилированное производное гиалуроновой кислоты, способ его получения, наномицеллярная композиция на его основе, способ ее получения и способ получения стабилизированной наномицеллярной композиции и ее применение
BRPI0714358B8 (pt) processo para fabricação de um lactil lactato de alquila
AR018357A1 (es) Acido petroselinico en una composicion y en un metodo para reducir o eliminar la irritacion o la picazon de la piel inducida por los alfa-hidroxiacidos
BR9812835A (pt) Composição de gel para barbear não-aerossol
BR112013004455A2 (pt) composições para fornecimento gástrico de agentes ativos
BR0111147A (pt) Composição condicionadora de tecidos, e, processo para preparar a mesma
AR110981A1 (es) Composiciones de biomasa que contienen pectina activada, productos y métodos para su producción
JP2007510690A5 (enExample)
BRPI0418070A (pt) composição para cuidados pessoais, uso de uma uréia substituìda e método para reduzir a degradação da cor de uma composição para cuidados pessoais
Sebastian et al. Facile one-pot multicomponent synthesis of peptoid based gelators as novel scaffolds for drug incorporation and pH-sensitive release
CO5160296A1 (es) Nuevas formas de presentacion para agentes activos labiles en medio acido, unidad de agente activo y proceso para la produccion de dicha unidad de agente
ATE469640T1 (de) Stabile pharmazeutische zusammensetzungen von zonisamide und verfahren zur deren herstellung
BR0208367A (pt) Composição farmacêutica de tratamento de infecções oculares por aplicação local, processo de preparação de uma composição farmacêutica de colìrio, e, utilização de azitromicina
ES2111938T3 (es) Composiciones para desodorizar heces animales y el correspondiente proceso desodorizante.
AR038298A1 (es) Sales estables del acido o-acetilsalicilico con aminoacidos basicos i i
CN103202773B (zh) 一种含液晶结构固体脂质纳米粒及其制备方法
CN102941044A (zh) 草莓多酚微胶囊的制备方法

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.